Metraipolis › archive › dc_f3ec334a70a4

Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy — Europe PMC PMID:42064464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42064464
DOI
10.1177/24741264261444276
License (as archived)
solo-consultazione
Archived
2026-11-03T02:37:21.597Z
SHA-256 of the archived text
dfbd80e145cb9f2ac9d3964a4e1f9dc033d35deeea8a7f41bba45bbcdcea7c37
Stable URL of this page
https://metraipolis.com/documento/dc_f3ec334a70a4

How to cite

Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy — Europe PMC PMID:42064464 — Europe PMC (en), https://europepmc.org/article/MED/42064464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3ec334a70a4 (Metraipolis archive dc_f3ec334a70a4, sha256 dfbd80e145cb9f2ac9d3964a4e1f9dc033d35deeea8a7f41bba45bbcdcea7c37)
BibTeX
@misc{dcf3ec334a70a4,
  title = {Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy — Europe PMC PMID:42064464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42064464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3ec334a70a4; sha256 dfbd80e145cb9f2ac9d3964a4e1f9dc033d35deeea8a7f41bba45bbcdcea7c37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42064464. Agents can read the archived copy with the MCP tool read_document.